Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Comparison of Bone Mineral Density in Lumbar Spine and Fracture Rate among Eight Drugs in Treatments of Osteoporosis in Men: A Network Meta-Analysis.

Chen LX, Zhou ZR, Li YL, Ning GZ, Zhang TS, Zhang D, Feng SQ.

PLoS One. 2015 May 26;10(5):e0128032. doi: 10.1371/journal.pone.0128032. eCollection 2015.

2.

[Combination of alendronate plus alfacalcidol in the treatment of osteoporosis. Rationale, preclinical data and clinical evidence].

Von Schacht E, Dambacher MA, Ringe JD, Dukas L.

MMW Fortschr Med. 2012 Apr 5;154 Suppl 1:10-21. Review. German.

PMID:
23427364
3.

[A-TOP research group/JOINT program].

Kuroda T, Miyakawa N, Miyazaki T, Shiraki M.

Nihon Rinsho. 2009 May;67(5):1017-21. Review. Japanese.

PMID:
19432126
4.

[New development in bisphosphonate treatment. Fracture prevention by bisphosphonates].

Hosoi T.

Clin Calcium. 2009 Jan;19(1):11-8. doi: CliCa09011118. Review. Japanese.

PMID:
19122260
5.
6.

[Current research in adequate treatment by Osteoporosis Research Group].

Orimo H, Miyakawa N, Kuroda T.

Clin Calcium. 2006 Sep;16(9):1500-7. Review. Japanese.

PMID:
16951475
7.

[Measures for osteoporosis in the dermatological field--vitamin D3 and bisphosphonate].

Okada N.

Clin Calcium. 2004 Oct;14(10):145-9. Review. Japanese.

PMID:
15577149
8.

[Evidence-based assessment of therapeutic agents of osteoporosis. Bisphosphonates, SERM and basic therapy in front].

[No authors listed]

MMW Fortschr Med. 2003 Jul 10;145(27-28):63. German. No abstract available.

PMID:
14587198
9.

Osteoporosis prevention and treatment.

Sambrook PN, Eisman JA.

Med J Aust. 2000 Mar 6;172(5):226-9. Review.

PMID:
10776395

Supplemental Content

Loading ...
Support Center